The FDA has approved the Dexcom Stelo Glucose Biosensor System for over-the-counter sales, making continuous glucose monitors (CGMs) accessible to non-insulin users and nondiabetics interested in tracking blood sugar levels. This action aims to improve health equity by allowing more Americans to make informed choices about their health without needing a prescription. The FDA has approved the Dexcom Stelo Glucose Biosensor System for over-the-counter sales, making continuous glucose monitors (CGMs) accessible to non-insulin users and nondiabetics interested in tracking blood sugar levels. This action aims to improve health equity by allowing more Americans to make informed choices about their health without needing a prescription. Health and Fitness, Health Tips, Exercises & Workout Tips, Diet & Wellness | Times of India Lifestyle
